NovaBridge Biosciences
NBP
$2.06
-$0.04-1.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -571.87% | 66.68% | -- | -- | -- |
| Total Depreciation and Amortization | 1.41% | 10.20% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,782.76% | -86.42% | -- | -- | -- |
| Change in Net Operating Assets | 1,009.56% | -61.12% | -- | -- | -- |
| Cash from Operations | -33.31% | -78.16% | -- | -- | -- |
| Capital Expenditure | 100.00% | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 3,216.67% | -87.81% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.56% | 186.27% | -- | -- | -- |